Launch week offerEnds in00h00m00s
annual Promonthly Pro
Joaquin Arribas
Has grant
Research Director
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Tumor-Intrinsic and Immune Determinants of Resistance to Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
Open Date: 2026-10-01
Close Date: 2027-09-30
Grant: Close
Immune Senolysis Against Breast Cancer
Open Date: 2024-10-01
Close Date: 2025-09-30
Grant: Close
Novel therapies against HER2-positive breast tumors: targeting oncogene-induced senescence and the immune system
Open Date: 2016-10-01
Close Date: 2017-09-30
Grant: Close
Targeting Oncogene-Induced Sensescence in Breast Cancer
Open Date: 2015-10-01
Close Date: 2016-09-30
Grant: Close
Anticipating resistances to novel anti-HER2 therapies
Open Date: 2014-10-01
Close Date: 2015-09-30
Articles (3)
Year:
2026
Year:
2023
Year:
2022
Collaborators (7)
Júlia Perera-Bel
Head of Bioinformatics Unit
Institut Hospital del Mar d'Investigacions Mèdiques
Cindy Neuzillet
PU PH
Université de Versailles Saint-Quentin-en-Yvelines
Lara Nonell
Head of bioinformatics unit
Vall d'Hebron Institute of Oncology
Marta Mele
Group leader
Barcelona Supercomputing Center
Teresa Macarulla
Head of Gastrointestinal and Endocrine Tumor Unit
Hospital Clínic de Barcelona
Verónica Rodilla Benito
Junior Group Leader
Josep Carreras Leukaemia Research Institute
TIAN TIAN
Vall d'Hebron Institute of Oncology
Make your next move.
Prepare your application
Review drafts before you send them.